Document Detail


Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function.
MedLine Citation:
PMID:  22293584     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We prospectively examined the additional effects of highly purified eicosapentaenoic acid (EPA) particularly on the vascular function of diabetic patients with hypercholesterolemia receiving statin therapy. We enrolled 28 patients with type 2 diabetes complicated by dyslipidemia who had been treated with statins for at least one year. The patients were randomly assigned to 2 groups: administration of statin alone (group S: n = 13) and addition of EPA to the current statin therapy (group SE: n = 15). The highly purified EPA was administered at a dose of 1,800 mg/day for 6 months. To evaluate vascular function, the duration of reactive hyperemia (DRH), which is the time required for forearm blood flow to return to the basal level after inducing reactive hyperemia, was measured using strain gauge plethysmography. There were no significant differences in the clinical background factors between the 2 groups. Low-density lipoprotein cholesterol (LDL-C), and non-high-density lipoprotein cholesterol levels significantly decreased after 6 months only in group SE. Compared with the baseline data, no significant change in DRH was observed after 6 months in group S. By contrast, DRH was significantly prolonged after 6 months in group SE, indicating that the addition of highly purified EPA improved vascular function. Our results showed that in patients with type 2 diabetes and receiving statin therapy whose LDL-C level was less than 100 mg/dL, the addition of highly purified EPA for 6 months significantly improved vascular function.
Authors:
Junko Sasaki; Takashi Miwa; Masato Odawara
Related Documents :
12093344 - Determinants for successful percutaneous image-guided drainage of intra-abdominal abscess.
3374144 - A new site for totally implanted central venous access system in patients with malignan...
6408274 - Central catheter fibrin sleeve--heparin effect.
9215844 - Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in...
8996334 - Ureteral anastomosis in the orthotopic ileal neobladder: comparison of 2 techniques.
8973854 - Intrauterine high dose rate afterloading brachytherapy: experience of fractionated ther...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-27
Journal Detail:
Title:  Endocrine journal     Volume:  -     ISSN:  1348-4540     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-2-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9313485     Medline TA:  Endocr J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University, Tokyo 160-0023, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early...
Next Document:  Association between insulin-like growth factor binding protein-2 levels and cardiovascular risk fact...